PXN and neoplasm: Retraction: Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by Norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway